Healthcare
Abu Dhabi expands AI and digital-health applications across clinical care
Abu Dhabi is expanding AI-enabled healthcare through clinical trials, hypertension programs, medical documentation tools, and digital-health partnerships.
AstraZeneca is investing $50 million in approximately 30 clinical trials with Cleveland Clinic Abu Dhabi, covering cardiovascular, renal, and metabolic diseases. The company is also working with Oracle and M42 to apply AI and real-world medical data to hypertension diagnosis, clinical-trial recruitment, and safety monitoring. M42 has introduced Ossi, an AI platform designed to summarize medical histories and support clinical documentation. These developments reflect Abu Dhabi’s growing role in combining healthcare delivery, clinical research, and AI-enabled workflows.
Original source: The National